Clinic-based Intervention to Promote Cervical Cancer Prevention Behaviors
- Conditions
- Cervical Cancer
- Interventions
- Behavioral: Step Up to PreventionBehavioral: Offered HPV vaccine only
- Registration Number
- NCT02046265
- Lead Sponsor
- University of Pennsylvania
- Brief Summary
The project is a clinical behavioral research project based at University of Pennsylvania. The goal of this research is to design a brief clinic-based, Nurse Practitioner-guided, and theory-based health promotion intervention to enhance cervical cancer prevention among young women ages 18-26 living in economically disadvantaged urban communities. The investigators will evaluate the intervention for feasibility, acceptability and preliminary efficacy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 60
- Age 18-26 years
- Not yet received the HPV vaccine
- Speak, read, and understand 5th grade level of English;
- Had vaginal sex with a male partner in the past 2 months.
• Currently pregnant and/or plan to be pregnant in next 6 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Step Up to Prevention:belief Step Up to Prevention Participant receives a one-on-one tailored educational session with a trained study team member and participant is offered the HPV vaccine only by their nurse practitioner in clinic. Step up to Prevention Step Up to Prevention Participant receives both the knowledge session and the tailored belief sessions and the participant is offered the HPV vaccine only by their nurse practitioner in clinic. This combined intervention is call Step Up to Prevention. Offered HPV vaccine only Offered HPV vaccine only Participant is offered the HPV vaccine only by their nurse practitioner in clinic. Step Up to Prevention: knowledge Step Up to Prevention Participant receives an individual computer-delivered information session and participant is offered the HPV vaccine only by their nurse practitioner in clinic.
- Primary Outcome Measures
Name Time Method Human Papilloma Virus (HPV) Vaccine #1 Acceptance For each participant, at end of first study visit. Will assess until all subjects enrolled in study.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hospital of the University of Pennsylvania, Outpatient Ob/GYN clinic
🇺🇸Philadelphia, Pennsylvania, United States